Enviar artigo por via de e-mail Conjugates of Prostate-Specific Membrane Antigen Ligands with Antitumor Drugs
- Autores: Uspenskaya A.A.1, Machulkin A.É.1, Mazhuga A.G.1,2, Beloglazkina E.K.1
-
Afiliações:
- Department of Chemistry, M. V. Lomonosov Moscow State University
- D. Mendeleev University of Chemical Technology of Russia
- Edição: Volume 53, Nº 4 (2019)
- Páginas: 288-297
- Seção: Article
- URL: https://ogarev-online.ru/0091-150X/article/view/245738
- DOI: https://doi.org/10.1007/s11094-019-01994-1
- ID: 245738
Citar
Acesso aberto
Acesso está concedido
Somente assinantes
Resumo
Conjugates for targeted delivery that are based on low-molecular-mass prostate specific membrane antigen (PSMA) inhibitors are widely used and developed because of the deficiencies of existing methods for treating and diagnosing prostate cancer. The major classes of low-molecular-mass PSMA inhibitors, drug classes, and their mechanisms of action are discussed. Therapeutic conjugates for targeted delivery that are based on them are analyzed. Structural features of the linker that affect the biological activity and selectivity are identified.
Palavras-chave
Sobre autores
A. Uspenskaya
Department of Chemistry, M. V. Lomonosov Moscow State University
Autor responsável pela correspondência
Email: uspenskaya.n@gmail.com
Rússia, GSP-1, Moscow, 199991
A. Machulkin
Department of Chemistry, M. V. Lomonosov Moscow State University
Email: uspenskaya.n@gmail.com
Rússia, GSP-1, Moscow, 199991
A. Mazhuga
Department of Chemistry, M. V. Lomonosov Moscow State University; D. Mendeleev University of Chemical Technology of Russia
Email: uspenskaya.n@gmail.com
Rússia, GSP-1, Moscow, 199991; Moscow, 125047
E. Beloglazkina
Department of Chemistry, M. V. Lomonosov Moscow State University
Email: uspenskaya.n@gmail.com
Rússia, GSP-1, Moscow, 199991
Arquivos suplementares
